SARAH MARTIN: Open Payments
NPI 1487343752 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 67 payments from 11 companies in 2025. Trend: 2023 $445 · 2024 $1,706 · 2025 $1,363
Food & beverage: $1,263Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $350 |
| ABBVIE INC. | 17 | $287 |
| Lilly USA, LLC | 12 | $158 |
| GENZYME CORPORATION | 2 | $139 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $104 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| UCB, Inc. | 3 | $80 |
| LEO Pharma Inc. | 3 | $76 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Galderma Laboratories, L.P. | 1 | $28 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, TALTZ, ILUMYA, Bimzelx, COSENTYX, RINVOQ.
Industry payments across AR — which companies pay providers there.
